Small cell lung cancer (SCLC) is characterized by aggressive and rapid growth and a tendency to develop early spread to distant sites including mediastinal lymph nodes, liver, bones, adrenal glands, and brain. The purpose of this study is to assess…
The purpose of ARTEMIDE-Lung04 is to assess the efficacy and safety of rilvegostomig compared with pembrolizumab monotherapy as 1L treatment in participants with mNSCLC and whose tumors express PD-L1.
The purpose of this study is to evaluate the efficacy and safety of divarasib and pembrolizumab compared with pembrolizumab and pemetrexed and carboplatin or cisplatin, for the first-line treatment of adult participants with KRAS G12C-mutated,…
32 publications
2026
Clinical kidney journal
PubMed • Publisher's site2026
JCO global oncology
PubMed • Publisher's site2026
Cancer medicine
PubMed • Publisher's site2025
Cancers
PubMed • Publisher's site2025
The oncologist
PubMed • Publisher's site